These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 24492617)

  • 1. Noncanonical activation of Notch1 protein by membrane type 1 matrix metalloproteinase (MT1-MMP) controls melanoma cell proliferation.
    Ma J; Tang X; Wong P; Jacobs B; Borden EC; Bedogni B
    J Biol Chem; 2014 Mar; 289(12):8442-9. PubMed ID: 24492617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch1 Autoactivation via Transcriptional Regulation of Furin, Which Sustains Notch1 Signaling by Processing Notch1-Activating Proteases ADAM10 and Membrane Type 1 Matrix Metalloproteinase.
    Qiu H; Tang X; Ma J; Shaverdashvili K; Zhang K; Bedogni B
    Mol Cell Biol; 2015 Nov; 35(21):3622-32. PubMed ID: 26283728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MT1-MMP and ADAM10/17 exhibit a remarkable overlap of shedding properties.
    Werny L; Grogro A; Bickenbach K; Bülck C; Armbrust F; Koudelka T; Pathak K; Scharfenberg F; Sammel M; Sheikhouny F; Tholey A; Linder S; Becker-Pauly C
    FEBS J; 2023 Jan; 290(1):93-111. PubMed ID: 35944080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the Conditions That Affect the Selective Processing of Endogenous Notch1 by ADAM10 and ADAM17.
    Alabi RO; Lora J; Celen AB; Maretzky T; Blobel CP
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metalloprotease ADAM10 is required for Notch1 site 2 cleavage.
    van Tetering G; van Diest P; Verlaan I; van der Wall E; Kopan R; Vooijs M
    J Biol Chem; 2009 Nov; 284(45):31018-27. PubMed ID: 19726682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling.
    Bozkulak EC; Weinmaster G
    Mol Cell Biol; 2009 Nov; 29(21):5679-95. PubMed ID: 19704010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. When MT1-MMP meets ADAMs.
    Wong HL; Cao R; Jin G; Chan KM; Cao Y; Zhou Z
    Cell Cycle; 2012 Aug; 11(15):2793-8. PubMed ID: 22801544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MT1-MMP dependent repression of the tumor suppressor SPRY4 contributes to MT1-MMP driven melanoma cell motility.
    Shaverdashvili K; Zhang K; Osman I; Honda K; Jobava R; Bedogni B
    Oncotarget; 2015 Oct; 6(32):33512-22. PubMed ID: 26392417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tetraspanin CD81 protein increases melanoma cell motility by up-regulating metalloproteinase MT1-MMP expression through the pro-oncogenic Akt-dependent Sp1 activation signaling pathways.
    Hong IK; Byun HJ; Lee J; Jin YJ; Wang SJ; Jeoung DI; Kim YM; Lee H
    J Biol Chem; 2014 May; 289(22):15691-704. PubMed ID: 24733393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of matrix metalloproteinase-2 and -9 and membrane-type 1 matrix metalloproteinase in melanocytic tumors of dogs and canine melanoma cell lines.
    Docampo MJ; Cabrera J; Rabanal RM; Bassols A
    Am J Vet Res; 2011 Aug; 72(8):1087-96. PubMed ID: 21801067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADAM10 is the constitutive functional sheddase of CD44 in human melanoma cells.
    Anderegg U; Eichenberg T; Parthaune T; Haiduk C; Saalbach A; Milkova L; Ludwig A; Grosche J; Averbeck M; Gebhardt C; Voelcker V; Sleeman JP; Simon JC
    J Invest Dermatol; 2009 Jun; 129(6):1471-82. PubMed ID: 18971959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAX2 regulates ADAM10 expression and mediates anchorage-independent cell growth of melanoma cells.
    Lee SB; Doberstein K; Baumgarten P; Wieland A; Ungerer C; Bürger C; Hardt K; Boehncke WH; Pfeilschifter J; Mihic-Probst D; Mittelbronn M; Gutwein P
    PLoS One; 2011; 6(8):e22312. PubMed ID: 21876729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of MMP-9 by membrane type-1 MMP/MMP-2 axis stimulates tumor metastasis.
    Li Z; Takino T; Endo Y; Sato H
    Cancer Sci; 2017 Mar; 108(3):347-353. PubMed ID: 27987367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
    J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proamyloidogenic effects of membrane type 1 matrix metalloproteinase involve MMP-2 and BACE-1 activities, and the modulation of APP trafficking.
    Paumier JM; Py NA; García-González L; Bernard A; Stephan D; Louis L; Checler F; Khrestchatisky M; Baranger K; Rivera S
    FASEB J; 2019 Feb; 33(2):2910-2927. PubMed ID: 30332299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion.
    Gangemi R; Amaro A; Gino A; Barisione G; Fabbi M; Pfeffer U; Brizzolara A; Queirolo P; Salvi S; Boccardo S; Gualco M; Spagnolo F; Jager MJ; Mosci C; Rossello A; Ferrini S
    Pigment Cell Melanoma Res; 2014 Nov; 27(6):1138-48. PubMed ID: 25124714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Redundancy and specificity of the metalloprotease system mediating oncogenic NOTCH1 activation in T-ALL.
    Sulis ML; Saftig P; Ferrando AA
    Leukemia; 2011 Oct; 25(10):1564-9. PubMed ID: 21625236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MT1-MMP modulates melanoma cell dissemination and metastasis through activation of MMP2 and RAC1.
    Shaverdashvili K; Wong P; Ma J; Zhang K; Osman I; Bedogni B
    Pigment Cell Melanoma Res; 2014 Mar; 27(2):287-96. PubMed ID: 24387669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase.
    Nakamura H; Suenaga N; Taniwaki K; Matsuki H; Yonezawa K; Fujii M; Okada Y; Seiki M
    Cancer Res; 2004 Feb; 64(3):876-82. PubMed ID: 14871815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The thiirane-based selective MT1-MMP/MMP2 inhibitor ND-322 reduces melanoma tumor growth and delays metastatic dissemination.
    Marusak C; Bayles I; Ma J; Gooyit M; Gao M; Chang M; Bedogni B
    Pharmacol Res; 2016 Nov; 113(Pt A):515-520. PubMed ID: 27687955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.